title: The efficacy and relative bioavailability of diclofenac resinate in rheumatoid arthritis patients.
abstract: The pharmacodynamics and pharmacokinetics of 75 mg resin-bound diclofenac (resinate) were compared with enteric-coated tablets containing 75 mg of diclofenac in a double-blind randomized crossover trial in 16 patients suffering from rheumatoid arthritis. Diclofenac was significantly faster absorbed from the resinate than from the enteric coated formulation (tlag = 0.454 h vs. 0.998 h, tmax = 1.41 h vs. 2.56 h) and reached lower peak concentrations (Cmax = 1.64 micrograms/ml vs. 2.59 micrograms/ml). No significant differences were found concerning the area under the plasma level-time curves and the mean residence times. Smaller variances were found for the tmax and the mean residence times in the group treated with diclofenac resinate. Onset and duration of analgesia, as assessed by visual analogue scales were similar in both treatment groups, but did not correlate with the plasma concentrations. Four patients experienced adverse effects including gastric pain, transaminase increases, proteinuria and plasma creatinin increase. No uncommon adverse effects were observed with the new preparation.
authors.affiliation: Institut für Klinische Pharmakologie, Charité der Humboldt-Universität Berlin, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Kurowski
authors.forename: H
authors.initials: H
authors.lastname: Menninger
authors.forename: E
authors.initials: E
authors.lastname: Pauli
mesh_terms: D000042:Absorption; D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001682:Biological Availability; D002792:Cholestyramine Resin / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use; D004008:Diclofenac / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use; D004311:Double-Blind Method; D004338:Drug Combinations; D016503:Drug Delivery Systems / Q000592:standards*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010147:Pain Measurement; D013608:Tablets, Enteric-Coated
chemical_list: D004338:Drug Combinations; D013608:Tablets, Enteric-Coated; D002792:Cholestyramine Resin; D004008:Diclofenac